[
    [
        {
            "time": "2021-10-11",
            "original_text": "复星医药：本集团实际对外担保金额按2021年10月11日汇率折合人民币约约216.09亿元 大额借贷担保",
            "features": {
                "keywords": [
                    "复星医药",
                    "大额借贷担保",
                    "对外担保"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药：本集团实际对外担保金额按2021年10月11日汇率折合人民币约约216.09亿元 大额借贷担保",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2021-10-12",
            "original_text": "复星医药：控股子公司拟设立合资公司，并认缴51%资本",
            "features": {
                "keywords": [
                    "复星医药",
                    "控股子公司",
                    "合资",
                    "认缴资本"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：控股子公司拟设立合资公司，并认缴51%资本",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-13",
            "original_text": "复星医药：控股子公司通过GMP符合性检查",
            "features": {
                "keywords": [
                    "复星医药",
                    "控股子公司",
                    "GMP符合性检查"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：控股子公司通过GMP符合性检查",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-14",
            "original_text": "复星医药：拟共同投资设立苏州星晨，于苏州市设立并运营营利性三级儿童医疗机构",
            "features": {
                "keywords": [
                    "复星医药",
                    "苏州星晨",
                    "儿童医疗机构"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：拟共同投资设立苏州星晨，于苏州市设立并运营营利性三级儿童医疗机构",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-15",
            "original_text": "复星北铃公共卫生应急产业与重症诊疗技术工程中心正式奠基开工",
            "features": {
                "keywords": [
                    "复星北铃",
                    "公共卫生",
                    "应急产业",
                    "重症诊疗"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "公共卫生"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星北铃公共卫生应急产业与重症诊疗技术工程中心正式奠基开工",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]